CNE100000L14
CNE100000L14
JINGHUA PHARM
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.459.957.150 | 1.402.088.293 | 4.1% |
| Cost of Revenue | 702.399.970 | 705.568.875 | 0.4% |
| Gross Profit | 757.557.179 | 696.519.419 | 8.8% |
| 473.198.743 | 435.534.294 | 8.6% | |
| Operating Income | 284.358.436 | 260.985.124 | 9.0% |
| Pretax Income | 303.605.839 | 293.318.342 | 3.5% |
| Net Income Common Stockholders | 219.284.779 | 212.651.535 | 3.1% |
| -- | -- | -- | |
| -- | -- | -- |